Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020734

Expand all

CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
2.75%;10GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.75%;10GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 002
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
2.75%;25GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.75%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 005
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
2.75%;5GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 2.75/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.75%;5GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 001
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
4.25%;10GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 4.25/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;10GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 008
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
4.25%;20GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 4.25/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;20GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 010
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
4.25%;25GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 4.25/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 011
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
4.25%;5GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 4.25/5 SULFITE FREE IN DEXTROSE 5% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 4.25%;5GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 007
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
5%;10GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5%;10GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 014
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
5%;15GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 5/15 SULFITE FREE IN DEXTROSE 15% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5%;15GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 015
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
5%;20GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 5/20 SULFITE FREE IN DEXTROSE 20% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5%;20GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 016
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
5%;25GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 5/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5%;25GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 017
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
5%;35GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 5/35 SULFITE FREE IN DEXTROSE 35% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5%;35GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 018
Approval Date: Sep 29, 1997
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

CLINIMIX 8/14 SULFITE FREE IN DEXTROSE 14% IN PLASTIC CONTAINER (AMINO ACIDS; DEXTROSE)
8%;14GM/100ML
Marketing Status: Prescription

Active Ingredient: AMINO ACIDS; DEXTROSE
Proprietary Name: CLINIMIX 8/14 SULFITE FREE IN DEXTROSE 14% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 8%;14GM/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020734
Product Number: 019
Approval Date: Apr 13, 2021
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information